JP2024526279A5 - - Google Patents
Info
- Publication number
- JP2024526279A5 JP2024526279A5 JP2023581040A JP2023581040A JP2024526279A5 JP 2024526279 A5 JP2024526279 A5 JP 2024526279A5 JP 2023581040 A JP2023581040 A JP 2023581040A JP 2023581040 A JP2023581040 A JP 2023581040A JP 2024526279 A5 JP2024526279 A5 JP 2024526279A5
- Authority
- JP
- Japan
- Prior art keywords
- long
- semaglutide
- pharmaceutical composition
- parenteral pharmaceutical
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163218405P | 2021-07-05 | 2021-07-05 | |
| US63/218,405 | 2021-07-05 | ||
| US17/534,533 | 2021-11-24 | ||
| US17/534,533 US11865213B2 (en) | 2021-07-05 | 2021-11-24 | Semaglutide depot systems and use thereof |
| PCT/IL2022/050708 WO2023281495A1 (en) | 2021-07-05 | 2022-07-04 | Semaglutide depot systems and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526279A JP2024526279A (ja) | 2024-07-17 |
| JP2024526279A5 true JP2024526279A5 (https=) | 2025-07-10 |
Family
ID=84801375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581040A Pending JP2024526279A (ja) | 2021-07-05 | 2022-07-04 | セマグルチドデポー系及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11865213B2 (https=) |
| EP (1) | EP4366759A4 (https=) |
| JP (1) | JP2024526279A (https=) |
| AU (1) | AU2022308705A1 (https=) |
| CA (1) | CA3220567A1 (https=) |
| IL (1) | IL309789A (https=) |
| MX (1) | MX2024000050A (https=) |
| WO (1) | WO2023281495A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11865213B2 (en) * | 2021-07-05 | 2024-01-09 | Mapi Pharma Ltd. | Semaglutide depot systems and use thereof |
| NL2036269B1 (en) | 2023-11-14 | 2025-05-23 | Nanomi B V | Peptide microparticle compositions and related methods |
| KR102930984B1 (ko) * | 2024-01-29 | 2026-02-25 | 주식회사 티온랩테라퓨틱스 | 세마글루타이드의 개선된 의료 요법 제공을 위한 비만 및 당뇨 치료용로써, 소수성 이온 페어링 겔레이션을 통한 초기 방출이 제어된 데포 조성물 및 이의 제조방법 |
| WO2025165146A1 (ko) * | 2024-01-29 | 2025-08-07 | 주식회사 티온랩테라퓨틱스 | 세마글루타이드 또는 티르제파타이드의 개선된 의료 요법 제공을 위한 비만 및 당뇨 치료용으로써, 소수성 이온 페어링 겔레이션을 통한 초기 방출이 제어된 데포 조성물 및 이의 제조방법 |
| WO2025229403A1 (en) * | 2024-05-02 | 2025-11-06 | Camurus Ab | Lipid compositions and methods of use thereof |
| CN121015560B (zh) * | 2025-10-30 | 2026-01-30 | 上海银诺医药技术有限公司 | 依苏帕格鲁肽α纳米冻干胶束及其制备方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008021531A2 (en) * | 2006-08-17 | 2008-02-21 | University Of Massachusetts | Stabilized emulsions, methods of preparation, and related reduced fat foods |
| TWI362947B (en) * | 2007-03-08 | 2012-05-01 | Univ Kaohsiung Medical | Controlled release pharmaceutical composition and manufacture method thereof |
| HUE060304T2 (hu) | 2010-01-04 | 2023-02-28 | Mapi Pharma Ltd | Glatiramer acetátot tartalmazó depó rendszer |
| EP2866825B1 (en) * | 2012-07-01 | 2020-04-08 | Novo Nordisk A/S | Use of long-acting glp-1 peptides |
| BR112016022550B1 (pt) * | 2014-03-31 | 2023-03-28 | Pharmathen S.A | Processo para a preparação de microesferas de plga de acetato de octreotida |
| CN105963257B (zh) * | 2016-04-26 | 2021-01-22 | 广州帝奇医药技术有限公司 | 一种缓释微粒的制备方法 |
| CN105963258B (zh) * | 2016-04-26 | 2021-01-22 | 广州帝奇医药技术有限公司 | 一种缓释微粒的制备方法 |
| CN109982712A (zh) | 2016-08-31 | 2019-07-05 | Mapi医药公司 | 包含醋酸格拉替雷的储库系统 |
| CA3040906A1 (en) * | 2016-10-20 | 2018-04-26 | Peptron, Inc. | Methods of delivering a neuroprotective polypeptide to the central nervous system |
| US20190380967A1 (en) | 2017-01-23 | 2019-12-19 | Savior Lifetec Corporation | Preparation of microparticles of an active ingredient |
| KR102047983B1 (ko) | 2017-11-30 | 2019-11-22 | 주식회사 지투지바이오 | 안전성 및 저장 안정성이 향상된 생분해성 미립구의 제조방법 |
| CN110101846B (zh) | 2018-02-01 | 2022-09-23 | 齐鲁制药有限公司 | 一种低突释率的索玛鲁肽微球及其制备方法 |
| US20210162013A1 (en) | 2018-08-03 | 2021-06-03 | Brown University | Compositions and methods for improving the bioavailability of glp1 and analogues thereof |
| US20220183964A1 (en) | 2019-04-11 | 2022-06-16 | Foundry Therapeutics, Inc. | Implantable polymer depots for the controlled, sustained release of therapeutic agents |
| JP7336813B2 (ja) | 2019-07-29 | 2023-09-01 | ペプトロン インコーポレイテッド | レボドパ誘発性ジスキネジアの治療または進行抑制用の薬学組成物 |
| CN113018277B (zh) * | 2019-12-25 | 2023-10-31 | 丽珠医药集团股份有限公司 | 注射用缓释制剂及其制备方法 |
| CN115484935A (zh) | 2020-02-14 | 2022-12-16 | G2G生物公司 | 包括含有glp-1类似物或其药学上可接受的盐的缓释微球的药物组合物 |
| WO2022003662A1 (en) * | 2020-06-29 | 2022-01-06 | Mapi Pharma Ltd. | Low burst-release liraglutide depot systems |
| US11865213B2 (en) * | 2021-07-05 | 2024-01-09 | Mapi Pharma Ltd. | Semaglutide depot systems and use thereof |
| AU2023234747A1 (en) * | 2022-03-17 | 2024-09-12 | Mapi Pharma Ltd. | Depot systems comprising cariprazine or salts thereof |
-
2021
- 2021-11-24 US US17/534,533 patent/US11865213B2/en active Active
-
2022
- 2022-07-04 JP JP2023581040A patent/JP2024526279A/ja active Pending
- 2022-07-04 IL IL309789A patent/IL309789A/en unknown
- 2022-07-04 WO PCT/IL2022/050708 patent/WO2023281495A1/en not_active Ceased
- 2022-07-04 AU AU2022308705A patent/AU2022308705A1/en active Pending
- 2022-07-04 MX MX2024000050A patent/MX2024000050A/es unknown
- 2022-07-04 EP EP22835557.4A patent/EP4366759A4/en active Pending
- 2022-07-04 CA CA3220567A patent/CA3220567A1/en active Pending
-
2023
- 2023-12-19 US US18/544,721 patent/US20240148653A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024526279A5 (https=) | ||
| IL309789A (en) | Semaglutide storage systems and their use | |
| CN103338752B (zh) | 利培酮缓释微球组合物 | |
| CN102316867B (zh) | 氨氯地平微球制剂、其制备方法及应用 | |
| JP2016515612A (ja) | ドネペジルを含む非経口投与用の医薬組成物 | |
| KR20220112737A (ko) | 리바스티그민을 포함하는 장기지속형 제제 및 이의 제조방법 | |
| CN117715625A (zh) | 用于治疗晶体和非晶体相关急性炎症性关节炎的包含秋水仙碱的关节内注射用剂型 | |
| JP2016527308A (ja) | エンテカビル微小球及びこれを含む非経口投与用医薬組成物 | |
| CN117530933B (zh) | 一种吡仑帕奈长效缓释微球、制备方法及缓释注射剂 | |
| CN121013711A (zh) | 用于治疗关节病诸如骨关节炎的包含秋水仙碱的关节内注射剂型 | |
| PL188128B1 (pl) | Sposób wytwarzania preparatów flawanolignanowych o zwiększonej zdolności do uwalniania i resorpcji | |
| CN103948911B (zh) | 一种棘白菌素类抗真菌药物缓释微球制剂及其制备方法 | |
| CN116098872A (zh) | 一种注射用阿哌沙班长效微球及其制备方法 | |
| CN116099007A (zh) | 一种局麻药与生物碱的帕莫酸盐缓释组合物 | |
| CN100423719C (zh) | 一种多烯紫杉醇纳米粒及其制备方法 | |
| CN102293748A (zh) | 一种口服聚乙二醇化胰岛素pH敏感纳米粒及其制备方法 | |
| KR20240060874A (ko) | 타크롤리무스를 포함하는 약제학적 제형, 이의 제조 방법 및 용도 | |
| CN114025746B (zh) | 抗血栓形成剂的可注射聚合物纳米颗粒组合物及其方法 | |
| CN104825399B (zh) | 包载康普瑞丁磷酸二钠的反胶束-微球缓释制剂及其制备方法 | |
| CN113786393A (zh) | 一种利伐沙班微球及其制备方法与应用 | |
| DE102020124431A1 (de) | Extrudierte Depotform mit kontrollierter Wirkstofffreisetzung | |
| CN1204922C (zh) | 新的眼科用组合物 | |
| CN101254169A (zh) | 含抗结核病药物的缓释剂 | |
| US20220241208A1 (en) | Pharmaceutical compositions for the treatment of hbv | |
| EP4360619A1 (en) | Dosage form for intra-articular injection comprising colchicine and an anesthesic agent in the treatment of crystal-and non-crystal associated acute inflammatory arthritis |